花旗集团在7月30日将药明康德(2359.HK)的持仓比例从7%提升至8.59%，据香港交易所信息披露。（或）根据香港交易所8月5日公布的信息，花旗集团在7月30日增加了对药明康德(2359.HK)的持仓，从原先的7%提升至8.59%，显示出对该公司的进一步看好。（或）7月30日，花旗集团对药明康德(2359.HK)的持仓比例进行了上调，由7%增至8.59%，此变动已在香港交易所的信息平台上公布。...
Source Link花旗集团在7月30日将药明康德(2359.HK)的持仓比例从7%提升至8.59%，据香港交易所信息披露。（或）根据香港交易所8月5日公布的信息，花旗集团在7月30日增加了对药明康德(2359.HK)的持仓，从原先的7%提升至8.59%，显示出对该公司的进一步看好。（或）7月30日，花旗集团对药明康德(2359.HK)的持仓比例进行了上调，由7%增至8.59%，此变动已在香港交易所的信息平台上公布。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.